LASA SUPERGENERICS | TWILIGHT LITAKA PH. | LASA SUPERGENERICS/ TWILIGHT LITAKA PH. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -5.5 | -0.0 | - | View Chart |
P/BV | x | 1.3 | - | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
LASA SUPERGENERICS TWILIGHT LITAKA PH. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
LASA SUPERGENERICS Mar-24 |
TWILIGHT LITAKA PH. Jun-14 |
LASA SUPERGENERICS/ TWILIGHT LITAKA PH. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 41 | 7 | 577.6% | |
Low | Rs | 18 | 2 | 920.5% | |
Sales per share (Unadj.) | Rs | 20.8 | 12.7 | 163.8% | |
Earnings per share (Unadj.) | Rs | -4.3 | -56.6 | 7.7% | |
Cash flow per share (Unadj.) | Rs | -2.2 | -54.4 | 4.1% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 19.3 | -53.4 | -36.1% | |
Shares outstanding (eoy) | m | 50.10 | 24.78 | 202.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.4 | 0.4 | 397.7% | |
Avg P/E ratio | x | -6.8 | -0.1 | 8,498.6% | |
P/CF ratio (eoy) | x | -13.3 | -0.1 | 16,058.6% | |
Price / Book Value ratio | x | 1.5 | -0.1 | -1,802.6% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 1,475 | 112 | 1,317.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 54 | 48 | 111.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 1,043 | 315 | 331.2% | |
Other income | Rs m | 1 | 0 | 2,550.0% | |
Total revenues | Rs m | 1,044 | 315 | 331.5% | |
Gross profit | Rs m | -66 | -1,344 | 4.9% | |
Depreciation | Rs m | 107 | 54 | 197.9% | |
Interest | Rs m | 20 | 4 | 487.0% | |
Profit before tax | Rs m | -191 | -1,402 | 13.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 26 | 0 | - | |
Profit after tax | Rs m | -217 | -1,402 | 15.5% | |
Gross profit margin | % | -6.3 | -426.6 | 1.5% | |
Effective tax rate | % | -13.7 | 0 | - | |
Net profit margin | % | -20.8 | -445.0 | 4.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 379 | 2,185 | 17.3% | |
Current liabilities | Rs m | 489 | 4,244 | 11.5% | |
Net working cap to sales | % | -10.5 | -653.6 | 1.6% | |
Current ratio | x | 0.8 | 0.5 | 150.6% | |
Inventory Days | Days | 2 | 118 | 2.1% | |
Debtors Days | Days | 125 | 2,420,882,912 | 0.0% | |
Net fixed assets | Rs m | 1,130 | 1,129 | 100.1% | |
Share capital | Rs m | 501 | 124 | 404.3% | |
"Free" reserves | Rs m | 466 | -1,447 | -32.2% | |
Net worth | Rs m | 967 | -1,323 | -73.1% | |
Long term debt | Rs m | 0 | 332 | 0.0% | |
Total assets | Rs m | 1,509 | 3,313 | 45.5% | |
Interest coverage | x | -8.6 | -341.8 | 2.5% | |
Debt to equity ratio | x | 0 | -0.3 | -0.0% | |
Sales to assets ratio | x | 0.7 | 0.1 | 727.4% | |
Return on assets | % | -13.1 | -42.2 | 31.0% | |
Return on equity | % | -22.5 | 106.0 | -21.2% | |
Return on capital | % | -17.7 | 141.1 | -12.5% | |
Exports to sales | % | 4.2 | 0 | - | |
Imports to sales | % | 0.2 | 0 | - | |
Exports (fob) | Rs m | 44 | NA | - | |
Imports (cif) | Rs m | 2 | NA | - | |
Fx inflow | Rs m | 44 | 0 | - | |
Fx outflow | Rs m | 2 | 0 | - | |
Net fx | Rs m | 43 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 21 | 15 | 140.7% | |
From Investments | Rs m | -4 | -4 | 111.2% | |
From Financial Activity | Rs m | -19 | -7 | 293.2% | |
Net Cashflow | Rs m | -2 | 5 | -38.0% |
Indian Promoters | % | 53.7 | 17.3 | 310.5% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 46.4 | 82.7 | 56.0% | |
Shareholders | 27,968 | 0 | - | ||
Pledged promoter(s) holding | % | 20.7 | 0.0 | - |
Compare LASA SUPERGENERICS With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | LASA SUPERGENERICS | TWILIGHT LITAKA PH. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.93% | -4.95% | 1.23% |
1-Month | -5.19% | -20.00% | -0.24% |
1-Year | -5.95% | -28.18% | 43.62% |
3-Year CAGR | -24.56% | -35.39% | 20.35% |
5-Year CAGR | 6.11% | -23.06% | 26.24% |
* Compound Annual Growth Rate
Here are more details on the LASA SUPERGENERICS share price and the TWILIGHT LITAKA PH. share price.
Moving on to shareholding structures...
The promoters of LASA SUPERGENERICS hold a 53.7% stake in the company. In case of TWILIGHT LITAKA PH. the stake stands at 17.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of LASA SUPERGENERICS and the shareholding pattern of TWILIGHT LITAKA PH..
Finally, a word on dividends...
In the most recent financial year, LASA SUPERGENERICS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
TWILIGHT LITAKA PH. paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of LASA SUPERGENERICS, and the dividend history of TWILIGHT LITAKA PH..
For a sector overview, read our pharmaceuticals sector report.
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.